parenteral nutrition associated liver disease
Conditions
Interventions
period:8weeks frequency:6days/week dose:0.5 to 1.5g/kg/day
Sponsors
Self procurance
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Direct bilirubin>2.0mg/dl continues more than two weeks
Exclusion criteria
Exclusion criteria: Liver disease caused by other illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Direct bilirubin | — |
Countries
Japan
Contacts
Public ContactMegumi Nakamura
Tohoku University Graduate School of Medicine Department of Pediatric Surgery
Outcome results
None listed